Lékům vdechujeme reálný život

 

Publikace


Impaktované publikace


2022

Štrosová D, Tužil J, Velacková Turková B, Filková Pilnáčková B, Lžičařová de Souza L, Doležalová H, Rašková M, Dufek M, Doležal T: Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of Teriflunomide, Pharmaceuticals 2022, Volume 15, Issue 10, 1248

Ornstová E, Tužil J, Chadimová K, Mlčoch T & Doležal T: Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension, Expert Review of Pharmacoeconomics & Outcomes Research (2022)

Turková B, Tužil J, Pilňáčková B, Doležalová H, Štrosová D, Petrů V, Seberová E & Doležal: Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic, Immunotherapy , Future Medicine (2022)

Tichy M, Kojanova M, Velackova B, Dolezal T, Spyridon Gkalpakiotis, Cetkovska P, BIOREP Study Group: Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP), Dermatologic Therapy (2022)

Kojanova M, Hugo J, Velackova B, Cetkovska P, Fialova J, Dolezal T, Tichy M, Spyridon Gkalpakiotis, BIOREP Study Group: Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry, Journal of Dermatological Treatment (2022)

Tánczosová M, Kojanová M, Arenbergerová M, Arenberger P, Doležal T, Štrosová D, Fialová J, Spyridon Gkalpakiotis : Real-life experience on the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic, Central European Journal of Public Health (2022)

Kojanova M, Tanczosova M, Strosova D, Cetkovska P, Fialova J, Dolezal T, Machovcova A, Spyridon Gkalpakiotis & on behalf of the BIOREP Study Group (2022): Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry, Journal of Dermatological Treatment (2022)

Štrosová D, Tužil J, Pilnáčková B, Lžičařová L, Typovská V, Doležalová H, Herold M, Doležal T, Vnitřní lékařství (2022)

 

2021

Matějka J, Varvařovský I, Tužil J, Doležal T, Bobak M, Pospíchal J, Geier P, Vondrák J, Bláha K, Málek J, Staňková A, Bujdák J, Rozsíval V, Novotný V, Lazarák T, Plíva M, Večeřa J, Vojtíšek P, Cerebrovascular Diseases Extra (2021)

Tužil J, Mlčoch T, Závada J, Svoboda M, Pavelka K, Doležal T, Rheumatology (2021)

Tužil J, Bartáková J, Watt T, Doležal t, Expert Review of Pharmacoeconomics & Outcomes Research, e-publication, ahead of print (2021)

Kubeš J, Haas A, Vondráček V, Andrlík M, Navrátil M, Slavíková S, Vítek P, Dědečková K, Prausová J, Ondrová B, Vinakurau Š, Grebenyuk A, Doležal T, Velacková B, Rosina J, Radiation Oncology 2021; 110(4): P1090-1097 (2021)

Gkalpakiotis SCetkovska PArenberger P Dolezal T Arenbergerova MVelackova B Fialova J Kojanova MBIOREP study group, Dermatol Ther (Heidelb) (2021)

Kojanova M, Cetkovaska P, Strosova D, Fialova J, Arenberger P, Dolezal T, Gkalpakiotis S, & The BIOREP Study Group. Dermatology and Therapy (2021)

Tužil J, Filková B, Malina J, Kerestes J, Doležal T. Česká gynekologie (2021)

Kojanova M, Fialova J, Cetkovska P,  Dolezal T, Lomicova I, Arenberger P, Gkalpakiotis S, the BIOREP Study Group. Dermatologic therapy (2021)


Mlcoch T, Decker B, Dolezal T, Applied Health Economics and Health Policy 2021 (19): 593-604 (2021)

 

2020

Zemanova M, Jakopovic M, Stanic K, Łazar-Poniatowska M, Vrankar M, Rusu P, Ciuleanu T, Radosavljevic D, Bogos K, Nawrocki S,Ve spolupráci, Radiol Oncolol 2020; 54(4): 447-454 (2020)

Tuzil J, Filkova B, Jircikova J, Dolezalova H, Malina J, Decker B, Kerestes J, Gemerlova P, Cepicka Libalova Z, Dvorak V, Kacer V, Kosova H, Adamova Z, Dolezal T, JBAPN, Volume 10, Issue 5 (November 2020)


Fiala O, Finek J, Poprach A, Melichar B, Kopecký J, Zemanová M, Kopečková K, Mlčoch T, Doležal T, Čapková L, Buchler T, Cancers, Volume 12, Issue 4 (April 2020)

 

2019

Tužil J, Mlčoch T, Jirčíková J, Závada J, Nekvindová L, Svoboda M, Uher M, Křístková Z, Vencovský J, Pavelka K, Doležal T, Expert Opinion on Biological Therapy (2019)


Mlcoch T, Hrnciarova T, Tuzil J, Zadak J,  Marisca M, Dolezal T, Value in Health, August (2019)


Horakova DRockova P, Jircikova J, Doležal T, Vachova M, Hradilek P, Valis M, Sucha J, Martinkova A, Ampapa R, Grunermelova M, Stetkarova I, Stourac P, Mares J, Dufek M, Kmetova E, Adamkova J, Hrnciarova T,  Multiple Sclerosis and Related Disorders, October (2019): 196-202

 

2018

Ornstova E, Sebestianova M, Mlcoch T, Lamblova K, Dolezal T. Value in Health Regional Issues 16, September (2018): 92-98.


Rogalewicz V, Kubátová I, Donin G, Doležal T, Lamblová K, Bartáková J, Kneppo P World Congress on Medical Physics and Biomedical Engineering 2018 (Vol. 2). Springer Nature Singapore Pte Ltd., 2019. IFMBE Proceedings. vol. 68/2. ISSN 1680-0737. ISBN 978-981-10-9037-0.


Adenubiova E, Arenberger P, Gkalpakioti P, Arenbergerova M, Jircikova J, Dolezal T, Gkalpakiotis S. J Dermatolog Treat. 2018 Jan 17: 1-4. doi: 10.1080/09546634.2018.1425358. [Epub ahead of print].

 

2017

Kojanova M, Fialova J, Cetkovska P, Gkalpakiotis S, Jircikova J, Dolezal T, Arenberger P. BIOREP study group. Int J Dermatol. 2017 Apr; 56(4): 428-434.


Havrdova E, Kobelt G, Berg J, Capsa D, Gannedahl M, Dolezal T. European Multiple Sclerosis Platform. Mult Scler. 2017 Aug; 23 (2_suppl): 41-52.


Mlcoch T, Puda R, Jesina P, Lhotakova M, Sterbova S, Dolezal T. Eur J Clin Nutr. 2017 Jun 28. doi: 10.1038/ejcn.2017.102. [Epub ahead of print].


Mlcoch T, Tuzil J, Sedova L, Stolfa J, Urbanova M, Suchy D, Smrzova A, Jircikova J, Hrnciarova T, Pavelka K and Dolezal T. Patient 2017, Nov 22, doi: https://doi.org/10.1007/s40271-017-0285-1 . [Epub ahead of print].

 

2016

Mlčoch T, Klimeš J, Jirčíková J, Doležal T, Macek M et al. European Journal of Health Economics (2017): 18: 73-82. Accepted and published online in January 2016.


Mlčoch T, Šedová L, Štolfa J, Urbanová M, Suchý D, Smržová A, Jirčíková J, Pavelka K, Doležal T. Expert Review of Pharmacoeconomics & Outcomes Research 17(2): 203-211 (2017). Accepted and published online in June 2016.


Válková V, Jirčíková J, Trnková M, Steinerová K, Keslová P, Lánská M, Kořístek Z, Raida L, Kruntorádová K, Doležal T, Benešová K, Cetkovský P, Trněný M. Neoplasma. 2016 Jul 29; 63(5).


Jakubczyk M, Lipka I, Pawęska J, Niewada M, Rdzanek E, Zaletel J, Ramírez de Arellano A, Doležal T, Chekorova Mitreva B, Nagy B, Petrova G, Šarić T, Yfantopoulos J, Czech M.
J Med Econ. 2016 Oct; 19(10): 973-82.

 

2015

Doležal T, Kruntorádová K. Vnitřní lékařství 2015; 61 (SUppl 3): 3S50-53.

 

2014

Szmurło D, Fundament T, Ziobro M, Kruntorádová K, Doležal T, Głogowski C. Expert Rev Pharmacoecon Outcomes Res. 2014; 14(3): 451-458.


Kruntoradova K, Klimeš J, Sedova L, Stolfa J, Doležal T, Petříková A. Value in Health Regional Issues. 2014; 4C: 100-106.


Klimeš J, Vocelka M, Šedová L, Doležal T, Mlčoch T, Petříková A, Vlček J. Value in Health Regional Issues 4C (2014): 75-81.

 

2013

Petříková A, Doležal T, Klimeš J, Vocelka M, Šedová L, Kolář J. Rheumatol Int. 2013; 33: 1813-1819.